FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366393479> ?p ?o ?g. }

• W4366393479 endingPage "2358" @default.
• W4366393479 startingPage "2358" @default.
• W4366393479 abstract "The fundamental problem of dealing with cancer is that cancer cells are so like normal cells that it is very hard to find differences that can be a basis for treatment without severe side effects. The key to successful cancer immunotherapy will be based on a very careful choice of cancer targets that are sufficiently cancer specific not to cause serious side effects. There are two fundamentally different ways to deploy the immune system for such cancer treatments. One is to increase the efficacy of the cancer patient's own immune system so that it attacks these differences. This has been achieved by checkpoint blocking which is very successful but only with a relatively small proportion of cancers. Secondly, one can produce antibodies, or T cells, whose specificity is directed against proteins expressed differentially in cancers. CART cell treatments have proved very effective for some blood cancers but not so far for common solid tumours. Humanised, unmodified monoclonal antibodies have been used extensively for the treatment of certain adenocarcinomas with modest success. However, using antibodies together with the body's own immune system to treat cancers by engineering monoclonal antibodies that are directed at both a target antigen on the cancer cell surface and also against T cells shows promise for the development of novel immunotherapies. Genes can be found which are expressed highly in some cancers but with a low or absent expression on normal tissues and so are good novel targets. It is so far, only immune-based killing that can kill bystander target negative cells, which is essential for successful treatment since hardly ever will all the cells in a cancer express any desired target. We conclude that, while there still may be many hurdles in the way, engineered bispecific T cell attracting monoclonal antibody-mediated killing of cancer cells may be the most promising approach for achieving novel effective cancer immunotherapies." @default.
• W4366393479 created "2023-04-21" @default.
• W4366393479 creator A5004131652 @default.
• W4366393479 creator A5059982950 @default.
• W4366393479 date "2023-04-18" @default.
• W4366393479 modified "2023-10-01" @default.
• W4366393479 title "Cancer Immunotherapy: Where Next?" @default.
• W4366393479 cites W1487731794 @default.
• W4366393479 cites W1940241680 @default.
• W4366393479 cites W1987913042 @default.
• W4366393479 cites W1989053318 @default.
• W4366393479 cites W2000121076 @default.
• W4366393479 cites W2023386324 @default.
• W4366393479 cites W2044078071 @default.
• W4366393479 cites W2076215971 @default.
• W4366393479 cites W2079305869 @default.
• W4366393479 cites W2122618533 @default.
• W4366393479 cites W2141121704 @default.
• W4366393479 cites W2167550136 @default.
• W4366393479 cites W2261057385 @default.
• W4366393479 cites W2297219066 @default.
• W4366393479 cites W2341538622 @default.
• W4366393479 cites W2733984019 @default.
• W4366393479 cites W2747396160 @default.
• W4366393479 cites W2760942750 @default.
• W4366393479 cites W2901283619 @default.
• W4366393479 cites W2901751092 @default.
• W4366393479 cites W3021254998 @default.
• W4366393479 cites W3030079298 @default.
• W4366393479 cites W3128646645 @default.
• W4366393479 cites W3169689223 @default.
• W4366393479 cites W3193885942 @default.
• W4366393479 cites W3195593260 @default.
• W4366393479 cites W3214570726 @default.
• W4366393479 cites W4287307650 @default.
• W4366393479 cites W4310251912 @default.
• W4366393479 cites W4324148925 @default.
• W4366393479 doi "https://doi.org/10.3390/cancers15082358" @default.
• W4366393479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37190286" @default.
• W4366393479 hasPublicationYear "2023" @default.
• W4366393479 type Work @default.
• W4366393479 citedByCount "2" @default.
• W4366393479 countsByYear W43663934792023 @default.
• W4366393479 crossrefType "journal-article" @default.
• W4366393479 hasAuthorship W4366393479A5004131652 @default.
• W4366393479 hasAuthorship W4366393479A5059982950 @default.
• W4366393479 hasBestOaLocation W43663934791 @default.
• W4366393479 hasConcept C121608353 @default.
• W4366393479 hasConcept C126322002 @default.
• W4366393479 hasConcept C147483822 @default.
• W4366393479 hasConcept C159654299 @default.
• W4366393479 hasConcept C19106626 @default.
• W4366393479 hasConcept C203014093 @default.
• W4366393479 hasConcept C2777701055 @default.
• W4366393479 hasConcept C2780674031 @default.
• W4366393479 hasConcept C502942594 @default.
• W4366393479 hasConcept C542903549 @default.
• W4366393479 hasConcept C71924100 @default.
• W4366393479 hasConcept C8891405 @default.
• W4366393479 hasConcept C96232424 @default.
• W4366393479 hasConceptScore W4366393479C121608353 @default.
• W4366393479 hasConceptScore W4366393479C126322002 @default.
• W4366393479 hasConceptScore W4366393479C147483822 @default.
• W4366393479 hasConceptScore W4366393479C159654299 @default.
• W4366393479 hasConceptScore W4366393479C19106626 @default.
• W4366393479 hasConceptScore W4366393479C203014093 @default.
• W4366393479 hasConceptScore W4366393479C2777701055 @default.
• W4366393479 hasConceptScore W4366393479C2780674031 @default.
• W4366393479 hasConceptScore W4366393479C502942594 @default.
• W4366393479 hasConceptScore W4366393479C542903549 @default.
• W4366393479 hasConceptScore W4366393479C71924100 @default.
• W4366393479 hasConceptScore W4366393479C8891405 @default.
• W4366393479 hasConceptScore W4366393479C96232424 @default.
• W4366393479 hasIssue "8" @default.
• W4366393479 hasLocation W43663934791 @default.
• W4366393479 hasLocation W43663934792 @default.
• W4366393479 hasLocation W43663934793 @default.
• W4366393479 hasOpenAccess W4366393479 @default.
• W4366393479 hasPrimaryLocation W43663934791 @default.
• W4366393479 hasRelatedWork W1997716688 @default.
• W4366393479 hasRelatedWork W2038126255 @default.
• W4366393479 hasRelatedWork W2064089409 @default.
• W4366393479 hasRelatedWork W2220102944 @default.
• W4366393479 hasRelatedWork W2984962695 @default.
• W4366393479 hasRelatedWork W3028762050 @default.
• W4366393479 hasRelatedWork W4220665865 @default.
• W4366393479 hasRelatedWork W4291367166 @default.
• W4366393479 hasRelatedWork W4360983034 @default.
• W4366393479 hasRelatedWork W4366393479 @default.
• W4366393479 hasVolume "15" @default.
• W4366393479 isParatext "false" @default.
• W4366393479 isRetracted "false" @default.
• W4366393479 workType "article" @default.